SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

45 hedge funds and large institutions have $62.3M invested in Sinovac Biotech, Ltd in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less call options, than puts

Call options by funds: $ | Put options by funds: $

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$65K
Puts
$150K
Net Calls
Net Calls Change

Top Buyers

1
+$5.69M
2
+$4.39M
3
+$1.51M
4
Morgan Stanley
Morgan Stanley
New York
+$456K
5
Renaissance Technologies
Renaissance Technologies
New York
+$438K

Top Sellers

1
-$7.05M
2
-$5.64M
3
-$1.65M
4
BIM
Bogle Investment Management
Massachusetts
-$771K
5
HighTower Advisors
HighTower Advisors
Illinois
-$259K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$65K
27
$65K
28
$53K
29
$51K
30
$50K
31
$49K
32
$42K
33
$32K
34
$32K
35
$31K
36
$24.5K
37
$24K
38
$24K
39
$22K
40
$10K
41
$5K
42
$5K
43
$1K
44
$1K
45
$1K
46
–
47
–
48
–
49
–
50
–
1
2
3